Randomized, Controlled Trial With Hybrid Fractional Laser
NCT03647189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2021-06-18
Summary
This randomized, controlled trial will evaluate hybrid fractional laser treatment for vulvovaginal atrophy in breast cancer survivors and menopausal females
Conditions
- Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia
Interventions
- DEVICE
-
Hybrid Fractional Laser
Hybrid Fractional Laser
Sponsors & Collaborators
-
Sciton
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-10
- Primary Completion
- 2021-06-15
- Completion
- 2021-06-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Treatment
NCT04717245 ·Status: COMPLETED ·Phase: NA
-
Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors
NCT05713435 ·Status: RECRUITING ·Phase: NA
-
Vulvovaginal Atrophy Correction Using Neodymium Laser
NCT04735549 ·Status: COMPLETED ·Phase: NA
-
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
NCT02691936 ·Status: COMPLETED ·Phase: NA
-
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
NCT01984138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (RF-SGM)
NCT07034976 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.
NCT04657536 ·Status: UNKNOWN ·Phase: NA
-
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
NCT03740945 ·Status: WITHDRAWN ·Phase: PHASE3
-
MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study
NCT04606550 ·Status: WITHDRAWN ·Phase: NA
-
The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM)
NCT06318052 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
NCT00729469 ·Status: COMPLETED ·Phase: PHASE3
-
LASER and Radiofrequency and Genitourinary Syndrome of Menopause
NCT04045379 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
NCT00361569 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
NCT01122342 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy
NCT02967510 ·Status: COMPLETED ·Phase: PHASE2
-
Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors
NCT04705883 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
NCT00276094 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.
NCT02571127 ·Status: UNKNOWN ·Phase: PHASE4
-
Genital Laser Treatment in Postmenopausal Patients
NCT05631665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes
NCT02937805 ·Status: COMPLETED ·Phase: NA
-
Clinical and Cyto-histological Evaluation of Fractional CO2 Laser Treatment on Genito-Urinary Syndromes of Menopause Related to Vaginal Atrophy
NCT05151380 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause
NCT02638337 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
NCT05118685 ·Status: UNKNOWN ·Phase: PHASE1
-
Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment
NCT03833726 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy
NCT06514586 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3